P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-05-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000936260.48784.ae |
| _version_ | 1797283830137094144 |
|---|---|
| author | M. Roussel N. Texier R. Germain S. Sapra P. Paka N. Kerbouche X. Colin X. Leleu |
| author_facet | M. Roussel N. Texier R. Germain S. Sapra P. Paka N. Kerbouche X. Colin X. Leleu |
| author_sort | M. Roussel |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:37:28Z |
| format | Article |
| id | doaj.art-ed22e32c19b947a494c0b7524c89c709 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:37:28Z |
| publishDate | 2023-05-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-ed22e32c19b947a494c0b7524c89c7092024-03-02T16:40:25ZengWileyHemaSphere2572-92412023-05-017S2292910.1097/01.HS9.0000936260.48784.ae202305002-00052P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDYM. Roussel0N. Texier1R. Germain2S. Sapra3P. Paka4N. Kerbouche5X. Colin6X. Leleu71 Hématologie Clinique et Thérapie Cellulaire, CHU Dupuytren, Limoges, France2 Kappa Santé, Paris, France2 Kappa Santé, Paris, France3 GSK, Upper Providence, PA, USA3 GSK, Upper Providence, PA, USA4 GSK, Rueil-Malmaison, France4 GSK, Rueil-Malmaison, France5 Département d’Hématologie, Centre Hospitalier Universitaire, Université de Poitiers, Poitiers, Francehttp://journals.lww.com/10.1097/01.HS9.0000936260.48784.ae |
| spellingShingle | M. Roussel N. Texier R. Germain S. Sapra P. Paka N. Kerbouche X. Colin X. Leleu P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY HemaSphere |
| title | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_full | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_fullStr | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_full_unstemmed | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_short | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_sort | p33 effectiveness and safety of belantamab mafodotin in patients with relapsed refractory multiple myeloma in real life setting the alfa study |
| url | http://journals.lww.com/10.1097/01.HS9.0000936260.48784.ae |
| work_keys_str_mv | AT mroussel p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT ntexier p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT rgermain p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT ssapra p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT ppaka p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT nkerbouche p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT xcolin p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT xleleu p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy |